We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

2 hedge funds and large institutions have $1.94K invested in Biolase, Inc. in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% less funds holding

Funds holding: 18 → 2 (-16)

98% less capital invested

Capital invested by funds: $116K → $1.94K (-$114K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 16

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-16
Holders Change %
-88.89%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$27K
2
Millennium Management
Millennium Management
New York
-$22.1K
3
HF
HRT Financial
New York
-$19K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$9K
5
XT
XTX Topco
Cayman Islands
-$8.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
XT
1
XTX Topco
Cayman Islands
$1.94K -$8.5K -53,649 -73%
HNB
2
Huntington National Bank
Ohio
$1 – – –
VF
3
Virtu Financial
New York
– -$27K -143,537 Closed
Millennium Management
4
Millennium Management
New York
– -$22.1K -116,664 Closed
HF
5
HRT Financial
New York
– -$19K -101,143 Closed
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
– -$9K -50,000 Closed
Citadel Advisors
7
Citadel Advisors
Florida
– -$7.56K -39,829 Closed
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
– -$6.96K -36,649 Closed
KWA
9
Kellett Wealth Advisors
Ohio
– -$3.62K -19,060 Closed
Vanguard Group
10
Vanguard Group
Pennsylvania
– -$2.07K -10,911 Closed
Jane Street
11
Jane Street
New York
– -$1.92K -10,109 Closed
Bank of Montreal
12
Bank of Montreal
Ontario, Canada
– -$1.96K -10,040 Closed
Qube Research & Technologies (QRT)
13
Qube Research & Technologies (QRT)
United Kingdom
– -$759 -4,000 Closed
BlackRock
14
BlackRock
New York
– -$191 -1,007 Closed
TRCT
15
Tower Research Capital (TRC)
New York
– -$38 -200 Closed
FDCDDQ
16
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$7 -37 Closed
Wells Fargo
17
Wells Fargo
California
– -$5 -27 Closed
Fidelity Investments
18
Fidelity Investments
Massachusetts
– -$1 -5 Closed

BIOL Hedge Fund Activity: Q2 2024 in Review

2 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q2 2024, worth a combined $1.94K — down 98% from $116K a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of BIOL and 0 opened new positions — a net loss of 16 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Virtu Financial, exiting entirely with an estimated $27K sold.

  • 2 institutional investors held Biolase, Inc. (BIOL) as of Q2 2024, down from 18 in Q1 2024.
  • Funds reported $1.94K of Biolase, Inc. stock for Q2 2024, down 98% quarter-over-quarter.
  • 0 funds opened new Biolase, Inc. positions in Q2 2024 and 16 closed out, a net change of -16 holders.
  • The largest Biolase, Inc. seller in Q2 2024 was Virtu Financial, an estimated $27K sold.

Based on aggregated 13F filings for Q2 2024.